Natural Investments »

Takeda Pharmaceutical shares owned by Natural Investments

Quarter-by-quarter ownership of Takeda Pharmaceutical (TAK) shares owned by Natural Investments from 13F filings

Historical chart of Natural Investments investment in Takeda Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including Takeda Pharmaceutical held by Natural Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Takeda Pharmaceutical by Natural Investments

Quarter filed Position value Share count Share price at filing
2025-09-30 $192k 13k 14.57
2025-06-30 $194k 13k 15.44

More positions owned by Natural Investments

Berkshire Hathaway Inc Del Cl A (BRK.A)
Microsoft Corporation (MSFT)
Apple (AAPL)
Ishares Tr Esg Optimized (OEF)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl C (GOOG)
Tidal Trust I Adasina Social (FMKT)
Abbvie (ABBV)
Investment Managers Ser Tr I Axs Green Alpha (FPAS)
Etf Ser Solutions Us Vegan Climate (BGDV)
Ea Series Trust Stance Sustainab (QVAL)
Hannon Armstrong (HASI)
Home Depot (HD)
Manager Directed Portfolios Vert Glb Sust Re (SWP)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)

View all positions for Natural Investments

Top funds holding Takeda Pharmaceutical

Capital Research Global Investors
Morgan Stanley
UBS Group
Goldman Sachs Group
FMR
Brandes Investment Partners
Renaissance Technologies
BlackRock
Toronto-Dominion Bank
Arrowstreet Capital, Limited Partnership
Millennium Management
First Trust Advisors
Northern Trust
Qube Research & Technologies
Citadel Advisors

View all funds holding Takeda Pharmaceutical